Explore every episode of the podcast JHLT: The Podcast

JHLT: The Podcast continues its exploration of recent consensus documents this month by discussing "Assessing and Addressing Frailty in Candidates for Lung Transplantation: An ISHLT Consensus Statement."

The statement appears online now at JHLT, and a helpful companion perspective piece from the authors can be read in your October print issue of the Journal.

Today's guests are project leads Michaela Anderson, MD, MS, of the Hospital of the University of Pennsylvania, and Jonathan Singer, MD, MS, of the University of California San Francisco.

In their discussion, they cover:

• What real-world teams want to know about frailty and how their document enhances clinical capacity
• How programs decide which tools to use to use to measure frailty—and which are most relevant to lung transplantation
• The importance of—and best timing for—universal assessment
• What's next in studying frailty

Stay up to date with official standards and guidelines documents from ISHLT at ISHLT.org. For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Today, JHLT: The Podcast discusses the recent ISHLT consensus document "Baseline Lung Allograft Dysfunction: Definition, Timing, and Implications for Outcomes—An ISHLT Consensus Document."

Now available online at JHLT—and a helpful companion perspective piece from the authors appears in the print October issue of JHLT.

Today's guests are co-leads on the document, Jens Gottlieb, MD, of Hannover Medical School and Kieran Halloran, MD, MSc, of the University of Alberta.

They discuss:

• Why rapid increases in usage of "BLAD" in the literature meant it was time for a formal definition
• Major considerations and areas of debate during the writing process
• How clinicians should think about patients meeting the criteria for BLAD and how the evaluation of underlying etiologies took place
• Interpreting BLAD's potential relationship to CLAD

Stay up to date with official standards and guidelines documents from ISHLT at ISHLT.org. For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

In this episode, JHLT: The Podcast continues the Pulmonary Hypertension theme for the month, exploring the study "Long-Term outcomes of stent-based pulmonary angioplasty for isolated peripheral pulmonary artery stenosis," which appears in the September print issue of JHLT.

Today's guest is author Hiroto Shimokawahara, MD, of the Okayama Medical Center in Japan.

Dr. Shimokawahara's discussion with Digital Media Editor Van-Khue Ton covers:

• What the study contributes to the clinical literature with longer-term outcomes of stent-based pulmonary angioplasty in peripheral pulmonary artery stenosis (PPAS)
• How the diffuse nature of PPAS and the advanced stage of disease complicates treatment options
• The evolution of stent choices and technologies in the last 20 years of clinical practice at their center
• Ideal follow-up conditions for monitoring patients after PPAS stenting

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Today, JHLT: The Podcast discusses "Long-term effects of medical therapy pre- and post-pulmonary endarterectomy—insights from the UK CURATE registry," a manuscript available online now and in the September print issue of JHLT.

Today's guest is first author Paula Appenzeller, MD, of the National Pulmonary Vascular Diseases Unit at Royal Papworth Hospital in Cambridge.

In the episode, Dr. Appenzeller and the editors discuss:

• How findings from the UK CURATE registry challenge assumptions about pre-operative therapy in CTEPH
• What's important about the 6-minute walk distance test
• How hemodynamics help guide post-PEA treatment decisions
• If multimodal CTEPH treatment could become the norm

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

In this episode, JHLT: The Podcast explores the study "The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction," which appears in the August print issue of JHLT.

Today's guest is Daniel C. Chambers, MBBS, MD, of The Prince Charles Hospital and Queensland Lung Transplant Service in Brisbane, Australia.

From across the dateline, he and Digital Media Editor Erika Lease discuss:

• What inspired the team to explore the use of mesenchymal stromal cell (MSC) infusions in CLAD patients
• Preparation and treatment considerations for using MSCs
• How despite the negative outcome—the MSCs made no clear improvements in the patient groups—the study still pushes the field forward

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Today, JHLT: The Podcast discusses "Improved outcomes and donor utilization in heart transplantation with 10 °C static cold storage," a manuscript available online now and in the August print issue of JHLT.

Today's guest is senior author John Trahanas, MD, of the Vanderbilt University School of Medicine in Nashville, TN USA.

In the episode, Dr. Trahanas and the editors discuss:

• What was learned from the lung 10°C trials and how the team adapted the devices for hearts
• The improved outcomes in PGD and survivability observed in the 10°C group
• How to determine if switching from ice to 10°C actually changed donor selection practices—and how it enabled the team to use more hearts

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

In case you missed it, JHLT: The Podcast is re-releasing a past audience favorite for your listening pleasure. This month, we revisit a conversation regarding a study from the April 2025 issue of JHLT about the efficacy and safety of sotatercept in patients with PAH.

This conversation with Ioana Preston, MD, of the Tufts University School of Medicine in Boston, explores:

• What makes sotatercept unique as the first "biologic" in the treatment of PAH
• Hypotheses about the mechanism of action in sotatercept
• Sotatercept's interaction with mPAP and what it indicates about the drug's action on the pulmonary vasculature

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

JHLT: The Podcast returns for July with a paper entitled "Comparing DSA-negative and DSA-positive antibody-mediated rejection in heart transplants: Results from the Trifecta-Heart study," available online now and in the July print issue of JHLT.

Today's guests are first author Katelynn S. Madill-Thomsen, PhD and senior author Philip F. Halloran, MD, PhD, both from the Alberta Transplant Applied Genomics Center in Canada.

In the episode, the authors and editors discuss:

• Striking similarities—and key differences—in the DSA-negative and DSA-positive groups
• Changes to clinical practice based on the findings, including innovations from the kidney transplant community
• Future studies, including tools and therapies that could be explored for improved clinical outcomes

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

For the first time, JHLT: The Podcast welcomes a patient onto the podcast. The Digital Media Editors are pleased to welcome heart transplant recipient and patient advocate Payton Herres for a discussion about her recent perspective piece in JHLT.

In this compelling, moving discussion, Payton shares:

• Her treatment story—from her congenital diagnoses to her life-changing transplant—and her donor's story
• The difference between coverage and access—and how FDA labeling affected her access to an important component of her care
• What she wishes clinicians understood about long-term care of transplant patients

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On JHLT: The Podcast, we kick off June with a paper entitled "Serial assessment of modified Society for Cardiovascular Angiography and Interventions SHOCK classification in post-cardiotomy patients," which is available online now and in the June issue of JHLT.

Today's guests are first author Ufuk Baldan, MD and senior author Patrick Klein, MD, PhD, both of the Amsterdam University Medical Center in the Netherlands.

We discuss:

• The heterogeneous nature of post-cardiotomy shock and challenges to treat
• Should serial assessments become standardized post-cardiac surgery?
• Does SCAI staging overestimate risk—and how do we interpret the stages we observe immediately post-op?
• What's next for this line of research?

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this special episode of JHLT: The Podcast, the Digital Media Editors take a look back at the exciting science that was on display at ISHLT2026, the ISHLT 46th Annual Meeting & Scientific Sessions.

Topics include:

• Artificial intelligence and machine learning in transplantation, especially in assessing donor lungs and EVLP
• Cardiogenic Shock science at ISHLT2026, including a well-attended, all-new Academy
• The re-launch of the ISHLT International Thoracic Organ Transplant Registry, and the recent report in JHLT

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

JHLT: The Podcast starts May with an important ten-year update to a keystone document—the "ISHLT Consensus Conference on Graft Dysfunction within the First 72 Hours after Heart Transplantation." The consensus summary—and a perspective piece by the authors—appears in the May issue of JHLT, and is available in full on ISHLT.org.

The podcast is happy to host conference leader and first author Jon Kobashigawa, MD, Cedars-Sinai in Los Angeles, to talk about the consensus document, the conference, and PGD.

The conversation includes discussion of:

• Why the document needed updating and how consensus was achieved
• The revised severity scale for PGD and the omission of the vasoactive-inotropic score
• Changes from the old document, including:
  • Newer predictors of PGD
  • The latest donor preservation devices
  • Updated treatment approaches

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

In this episode, JHLT: The Podcast highlights a special issue of the Journal of Heart and Lung Transplantation that's just been released. The issue focuses on innovations in Device Therapies, and was edited by JHLT Deputy Editor Manreet Kanwar, MD, FACC, of the University of Chicago. Dr. Kanwar joins Digital Media Editor Van-Khue Ton, MD, PhD for a discussion about the special issue.

The discussion explores:

• The importance of discussing device therapies in the advanced heart and lung failure communities
• The most anticipated device therapies in the pipeline for clinicians and patients to consider
• The impact of publishing in JHLT

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Read the special issue on ScienceDirect or at the Journal website.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

JHLT: The Podcast kicks off April with a discussion of the paper, "Lung Cancer After Lung Transplantation: Early Detection and Curative Surgery Drive Long-Term Survival," which appears in the April issue of JHLT.

Senior author Pauline Pradère, MD, of Hôpital Marie Lannelongue in Paris, joins the episode to talk about the paper.

The conversation includes discussion of:

• The overall survival of patients who develop lung cancer after lung transplant—and the key differences between the cohort of patients who developed cancer versus the patients who did not
• Managing lung cancer in transplant recipients
• Immunosuppression in these patients, and other potential changes to clinical practice derived from the study

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

JHLT: The Podcast continues a themed month on HIV infection in solid organ transplant, building on our last episode's exploration from Dr. Saeed at Montefiore in New York.

Our guest this episode is infectious diseases expert Cameron Wolfe, MD, Professor of Medicine at Duke University Medical Center. He joined us while on sabbatical with his family in Brisbane Australia for a conversation about how transplant centers now consider HIV infection, including transplant recipients who are HIV positive.

The discussion explores:

• How the HOPE Act of 2013 changed practice in the United States, and how other countries have handled HIV transplantation regulations
• Immunosuppresion, antiviral therapy, and opportunistic infection in HIV+ transplant recipients
• Whether organ-specific surveillance changes in HIV+ patients
• The ethics of using organs from HIV+ donors and ensuring HIV+ patients are treated equitably

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

This month on JHLT: The Podcast, the Digital Media Editors host two themed discussions around HIV in solid organ transplantation. The conversation begins with a discussion of the paper, "Early experience in heart transplantation utilizing donors with HIV," which appears in the March issue of JHLT.

First author Omar Saeed, MD, MSc, of the Division of Cardiology at Montefiore Medical Center in New York, NY USA, joins the episode.

The conversation includes discussion of:

• The ethics and evolution of the Montefiore program's transplant eligibility and criteria
• The role of the HOPE Act in the changes to the program
• Superinfection, viral strain analysis, and informed consent of organ recipients
• Long-term patient follow upsa nd how other centers can begin this research

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Return later this month for a broader conversation with an infectious diseases expert about HIV in transplantation.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

JHLT: The Podcast returns with an episode  for our heart transplant colleagues, discussing the paper, "Barriers and opportunities in donation after circulatory death heart transplantation," from the February issue of JHLT.

Featured on this episode is first author, Katherine G. Phillips, MD, of the Department of Cardiothoracic Surgery at NYU Langone, and co-author, Brian Wayda, MD, from the Division of Cardiology at NYU Langone.

The discussion explores:

• Geographic variability on DCD heart utilization—why it happens and how to address
• Concerns around donor progression to circulatory arrest after life support withdrawal
• The volume of DCD hearts not utilized each year—and the gap between those successfully transplanted

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

In this episode of JHLT: The Podcast, the Digital Media Editors host a discussion on a new consensus statement from ISHLT on Short Telomere Syndrome (STS) and Lung Transplantation. The document was first published last month.

They're joined by document leads Andrew Courtwright, MD, PhD, of the University of Pennsylvania in Philadelphia; Dr. John Mackintosh of Prince Charles Hospital in Brisbane; and John McDyer, MD, of the University of Pittsburgh Medical Center in Pittsburgh.

The conversation includes discussion of:

• Recommendations for assessing patients for STS
• Which patients we should screen
• How the diagnosis influences transplant decision making and risk assessment
• How STS impacts immunosuppression
• Extrapulmonary comorbidities
• Future areas for research

ISHLT Standards, Guidelines, and Consensus Statements are open to all at ISHLT.org.

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Return later this month for a conversation on barriers and opportunities in utilizing DCD hearts in transplantation.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

JHLT: The Podcast returns with an episode discussing the paper, "Impact of evolocumab on coronary physiology and microstructure in de-novo heart transplant recipients," from the January issue of JHLT.

Featured on this episode is early career guest host Bin Yang, MD, of Massachusetts General Hospital. Mentored by Digital Media Editor Van-Khue Ton, MD, PhD, Dr. Yang shares hosting duties this episode and brings great questions to the discussion.

Drs. Yang and Ton are joined by the first author, Salma Karim, and senior author, Hans Eiskjaer, both from Aarhus University Hospital in Denmark.

The discussion explores:

• What imaging and physical markers the researchers used to determine if evolocumab was influencing the development of cardiac allograft vasculopathy (CAV)
• The potential role of lipid-lowering therapies or statins in treating CAV
• The relationship between CAV and microvascular resistance (IMR)

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

In case you missed it, earlier this month the JHLT Digital Media Editors recapped their favorite papers from 2025. Take a listen!

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Happy new year and welcome to a new season of JHLT: The Podcast! In this year-end recap, the Digital Media Editors will each share one of their favorite studies from The Journal of Heart and Lung Transplantation in 2025. You'll get a look at some of the best science in advanced heart and lung failure from the past year.

Studies featured:

• Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR
  Gomberg-Maitland M, et al. JHLT Apr 2025 44(4):609 – 624.
• A consensus-based framework for the psychosocial evaluation of pediatric candidates for cardiothoracic transplant and ventricular assist devices
  Lefkowitz DS, et al. JHLT Apr 2025 44(4):487-502.
• ABO-incompatible heart transplants in children aged 2-9 years: A new paradigm in transplant?
  Hollis P, et al. JHLT Dec 2025 44(12):1910-1917.
• Heart transplantation in Ukraine during wartime: A retrospective cohort study of standard vs marginal donor heart transplantation outcomes
  Todurov B, et al. JHLT Nov 2025 44(11):1728-1734.

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

JHLT: The Podcast returns with an episode discussing the paper, "High Antiphospholipid Antibody Titers and Outcomes of Pulmonary Endarterectomy: A Single-Center Retrospective Observational Cohort Study," from the December issue of JHLT.

They are joined by the first author, Camille Miard, MD, and senior author, François Stéphan, MD, PhD, both from the cardiothoracic intensive care unit at Hôpital Marie Lannelongue in Paris.

The discussion explores:

• Whether antiphospholipid antibody titers could predict postoperative outcomes for CTEPH patients undergoing pulmonary endarterectomy (PEA)
• How APS patients differed from non-APS patients in the PEA cohort
• The changes in clinical practice at Marie Lannelongue after the study's findings

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the Digital Media Editors host a discussion on the paper, "Lung transplant in patients with suspicious lung lesions: A single-center retrospective data analysis," which appears in the December issue of JHLT.

They are joined by the senior author, Stefan Schwarz, MD, PhD, of the Department of Thoracic Surgery at the Medical University of Vienna.

The discussion explores:

• Methods used to assess the probability of malignancy in the patient cohort
• The limitations of common scanning methods in assessing this type of transplant patient
• What the study confirms or changes about standards in clinical practice

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the Digital Media Editors host a discussion on the paper, "Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunction."

They are joined by the first author, Muhtadi Alnababteh, MD, Assistant Professor at the University of Maryland and Staff Clinician at the National Institutes of Health, and senior author Michael Keller, MD, of the Pulmonary and Critical Care division at the University of Maryland.

The discussion explores:

• Common characteristics of patients who developed donor-specific antibodies (DSA)
• Differences in outcomes depending on when DSA developed
• Associations between the development of DSA and antibody-mediated rejection, and related time frames

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the Digital Media Editors invite co-lead author Nir Uriel, MD, Director of Advanced Heart Failure and Cardiac Transplantation at New York Presbyterian Hospital and Professor of Medicine at Columbia University.

Dr. Uriel joins to discuss the work of the Cardiogenic Shock Working Group (CSWG) and their recent paper, "Outcomes of patients supported on Impella 5.5 for more than 14 days: A Cardiogenic Shock Working Group registry analysis."

The discussion explores:

• Why patients on longer duration of MCS had better survival but maintained similar rates of serious adverse events (SAEs)
• Why the study might show fewer SAEs than the literature historically shows
• How temporary MCS devices are selected in clinical settings in patients with cardiogenic shock
• The ongoing and upcoming activities of CSWG

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the Digital Media Editors invite author Dr. Ayumi Goda, from the Kyorin University Hospital in Tokyo, Japan, to discuss her team's paper, "Prevalence of occult HFpEF and age-specific efficacy of passive leg raise in pulmonary hypertension."

The discussion explores:

• How clinical observations led to the idea for a study on whether the passive leg raise could unmask occult HFpEF
• The potential diagnostic value of the passive leg raise in differing patient populations
• Age-specific cutoffs that may influence what kind of testing to use in clinical practice

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the Digital Media Editors invite first author Ahmet Bilgili, from the University of Florida's Congenital Heart Center, and senior author Eric I. Jeng, MD, from the University of Florida's MCS program.

Bilgili and Dr. Jeng discuss their paper, "Optimal pretransplant duration with HeartMate III left ventricular assist device: A contemporary analysis."

The discussion explores:

• Prior gaps in the literature regarding contemporary HM3 outcomes in relation to transplantation—and the study's potential influence on policy
• Which length of HM3 support influenced better post-transplant outcomes—and which ages were most influenced
• How these findings might change standard practice

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the Digital Media Editors invite first author Luke Williams, a cardiothoracic surgery trainee at Royal Papworth Hospital, NHS Blood and Transplant Clinical Research Fellow, and a PhD student at Cambridge University in the UK. Luke discusses his paper, "The United Kingdom's experience of controlled donation after circulatory death direct procurement of lungs with concomitant abdominal normothermic regional perfusion with an analysis of short-term outcomes."

The discussion explores:

• Requirements, regulations, and practices in the UK around DCD procurement and A-NRP
• How survival rates differ and what they might imply about primary graft dysfunction in DCD versus DBD
• Further work planned in the area in the UK and throughout Europe

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the Digital Media Editors invite first author Gaurav Sharma, PhD, MBA, from the University of Texas Southwestern Medical Center in Dallas. Dr. Sharma discusses his paper, "Metabolic and transcriptomic insights into temperature controlled hypothermic preservation of human donor hearts."

The discussion explores:

• How donor hearts not offered or declined for transplantation responded in hypothermic preservation versus conventional static cold storage
• Potentially beneficial genetic signatures yielded by TCHP versus cold storage
• The surprising response of energy stores in the hearts to the different storage environments
• How multi-omic approaches could be applied to other organs

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the Digital Media Editors invite first author Joan Guzmán-Bofarull, and senior author, Marta Farrero, both of the Hospital Clinic de Barcelona in Spain. They join to discuss their paper, "Regional differences in primary graft dysfunction: A report from the international consortium on PGD."

The discussion explores:

• The international consortium on PGD, the composition of the study, and the practices of the included countries in the United States, Canada, and Europe
• Hypotheses on why the study shows better 30-day and 1-year outcomes in the United States
• Considerations transplant centers can take regarding recipient management and donor heart selection

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the Digital Media Editors invite first author Nikil Prasad, MD, a cardiology fellow in the Columbia University Medical Center in New York, to discuss the paper, "Can the grading of mild cardiac allograft vasculopathy be further refined? An angiographic and physiologic assessment of heart transplant recipients with ISHLT CAV 1."

The discussion explores:

• The study's subdivisions of CAV grade 1 into CAV 1a and CAV 1b, based on the degree of coronary stenosis
• Differing clinical information provided by different methods of CAV screening: reduced myocardial blood flow reserve vs angiographic grading
• Limitations in implementing PET-based CAV assessments at various centers, and how transplant programs can use combined testing data

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this special episode of JHLT: The Podcast, the Digital Media Editors take a look back at the exciting science that was on display at ISHLT2025, the ISHLT 45th Annual Meeting & Scientific Sessions.

Topics include:

• Telomere biology disorders and lung transplantation
• The meeting's special focus on cardiogenic shock
• The apixiVAD trial exploring low dose apixaban in HeartMate 3 LVADs
• Myocardial recovery on durable LVADs

For the latest studies from JHLT, visit jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at ishlt.org/jhlt. Full-text abstracts of the meeting can also be found at the JHLT website.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the Digital Media Editors invite first author Peter Cho and senior author Abbas Ardehali, MD, to discuss the paper, "Severe primary graft dysfunction in heart transplant recipients using donor hearts after circulatory death: a United States Experience."

Peter is a third year medical student at Drexel University, and Dr. Ardehali is professor of surgery and medicine and the Director of the Heart, Lung, and Heart-Lung Transplant programs at UCLA.

The episode explores:

• The study's findings regarding an increased incidence of severe PGD at 24 hours post-transplant in DCD over DBD recipients
• What risks weren't changed in DCD recipients—suggesting that DCD PGD is likely to be transient, and may have a different phenotype
• How NRP may impact the outcomes
• Mitigating the risk of PGD

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Tune in again later this month for the Digital Media Editors' findings and observations from the ISHLT2025 Annual Meeting in Boston.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Returning for a second study this month, the JHLT Digital Media Editors invite first author Charlotte Van Edom to discuss the paper, "Apixaban plasma levels in patients with HeartMate 3 support."

As a cardiologist in training and a PhD candidate at the University Hospitals Leuven in Belgium, Van Edom's work focuses on hemocompatibility and mechanical circulatory support, covering both short-term and long-term support.

The episode explores:

• The evolution of the use and understanding of direct oral anticoagulants (DOACs) during LVAD support, including the increased focus on Factor Xa inhibitors
• Encouraging findings from the study and what clinical practices might need to change if introducing apixaban
• Additional studies exploring DOACs in LVAD patients

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Treat or research pulmonary vascular diseases? Check out the first April episode for a study on sotatercept in PAH patients.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the Digital Media Editors invite author Ioana Preston, MD, to discuss the paper, "Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR."

Dr. Preston is the director of the pulmonary hypertension center at Lahey Hospital and Medical Center in Burlington, Massachusetts, and has over 20 years of experience in caring for patients with PH, as well as multiple clinical trials in PH.

The episode explores:

• What makes sotatercept unique as the first "biologic" in the treatment of PAH
• Hypotheses about the mechanism of action in sotatercept
• Sotatercept's interaction with mPAP and what it indicates about the drug's action on the pulmonary vasculature

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Those involved in the heart failure and mechanical circulatory support should tune in again later this month for a study on apixaban plasma levels in patients with HeartMate 3 support.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Returning for a second study this month, the JHLT Digital Media Editors conduct an internal discussion on the paper, "Safety and efficacy of riociguat in patients with pulmonary arterial hypertension and cardiometabolic comorbidities: Data from interventional clinical trials."

The episode explores:

• The aging PAH population and the new comorbidities that must be considered in research
• How the study augments and expands on recent standards, like the 2022 ESC/ERS guidelines for pulmonary hypertension
• Limitations on the study and opportunities for future research

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Those on lung transplant teams should check the previous episode for a study on how rewarming ischemia time affects lung transplant outcomes.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the Digital Media Editors invite lead author Jan Van Slambrouck, MD, to discuss the paper, "The effect of rewarming ischemia on tissue transcriptome and metabolome signatures: A clinical observational study in lung transplantation."

Dr. Van Slambrouck is a general surgeon who's just finished his PhD training at the KU Leuven lab of respiratory disease and thoracic surgery in Belgium.

The episode explores: 

• How rewarming ischemia time (RIT) affects donor lungs, especially on the molecular level
• The pace of rewarming and how prior literature prepared the team to track and evaluate it
• Clinical strategies to reduce RIT and directly address molecular changes

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Those involved in the pulmonary vascular disease space should tune in again later this month for a study on the safety and efficacy of riociguat in patients with PAH.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Returning for a second study this month, the JHLT Digital Media Editors invite lead author Oliver J.F. Weiner, to discuss the paper, "Sympathetic reinnervation in cardiac transplant recipients: Prevalence, time course, and association with long-term survival."

Dr. Weiner is currently an out of training registrar at Monash Health in Melbourne, Australia, but will soon return to his home of the UK to begin internal medicine training with the intention becoming a cardiologist. He is especially interested in advanced heart failure and electrophysiology.

The episode explores:

• The uncertainty around clinical influences on reinnervation
• The importance of this single-center study in expanding the literature
• Potential future treatment options

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Those on lung transplant teams should check the previous episode for a study on recent trends and post-transplant outcomes from EVLP.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the Digital Media Editors invite lead author Jonathan E. Williams, MD, to discuss the paper, "Ex-Vivo Lung Perfusion: National Trends and Post-Transplant Outcomes."

Dr. Williams is a general surgery resident at the University of Michigan in Ann Arbor, with work focusing on contemporary lung preservation strategies, perfusion techniques, and particularly, EVLP.

The episode explores:

• How the study explores the theory that EVLP use may increase transplant volumes
• Preserving data quality and other study limitations
• How to work in fields of study that sometimes yield as many questions as answers

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Those on heart transplant teams should tune in again later this month for a study on sympathetic reinnervation in cardiac transplant recipients.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

JHLT: The Podcast returns with a year-end recap of 2024. Each Digital Media Editor shares one of their favorite studies from JHLT in 2024 for a quick recap of last year's excellent science in advanced heart and lung disease.

Studies featured:

·         Cardiac magnetic resonance assessment of acute rejection and cardiac allograft vasculopathy in pediatric heart transplant
Kikano, Sandra et al. JHLT May 2024 5(43):745-754

·         A modular simulation framework for organ allocation
Rose, Johnie et al. JHLT Aug 2024 8(43):1326-1335.

·         HeartMate 3 Snoopy: Noninvasive cardiovascular diagnosis of patients with fully magnetically levitated blood pumps during echocardiographic speed ramp tests and Valsalva maneuvers
Schlöglhofer, Thomas et al. JHLT Feb 2024 2(43):251-260.

·         Factors associated with acute limb ischemia in cardiogenic shock and downstream clinical outcomes: Insights from the Cardiogenic Shock Working Group
Kochar, Ajar et al. JHLT Nov 2024 11(43):1846-1856.

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Happy new year from JHLT: The Podcast! On this episode, the Digital Media Editors are joined by ISHLT Director of Marketing + Communications Jess Burke, CAE, to share a little bit about themselves and their backgrounds.

Hear about how each of the JHLT Digital Media Editors got involved in transplantation and a little about each of their research and personal interests.

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On the second December episode of JHLT: The Podcast, the Digital Media Editors explore another paper from the December issue of JHLT, entitled "Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial."

First author Entela Bollano, MD, PhD, and senior author Niklas Bergh, MD, PhD, both from the Sahlgrenska University Hospital in Sweden, join the podcast to discuss their work.

You'll hear about:

• Past outcomes of the SCHEDULE trial, including reduced CAV in patients on everolimus over patients on CNIs
• How this study filled the need for long-term follow up on randomized studies on immunosuppression
• Limitations of the study, and what additional follow up might teach us

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Lung clinicians: if you haven't yet tuned in for the first episode from this month, check it out! The paper discusses the effects of pollution post lung transplantation.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the Digital Media Editors invite lead author Chung-Wai Chow, MD, PhD, FRCPC, to discuss the paper, "Pollution exposure in the first 3 months post transplant is associated with lower baseline FEV1 and higher CLAD risk."

Dr. Chow is a transplant pulmonologist and clinician scientist at the University of Toronto, with work focusing on investigating air pollution's impact on chronic lung diseases and developing improved methods to assess lung function.

The episode explores:

• Measurement methods for home and personal air pollution exposures
• Specific pollutants like black carbon and their effects on patients after lung transplant
• Practical advice for mitigating these effects

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Those on heart transplant teams should tune in again later this month for a Scandinavian study that performs long-term follow ups with patients on the nephrotoxic effects of CNIs.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On the second November episode of JHLT: The Podcast, the Digital Media Editors continue MCS-month with a paper from the November issue of JHLT, entitled "Aortic insufficiency in the patient on contemporary durable left ventricular assist device support: A state-of-the-art review on perioperative and postoperative assessment and management." 

First author Diyar Saeed, MD, PhD, of the Heart Center Niderrhein, and senior author Jennifer Cowger, MD, MS, of Henry Ford Hospitals both join the podcast.

You'll hear about:

• Why LVAD patients develop new and progressive aortic regurgitation—and how contemporary devices may differ
• Associated hemodynamic events
• Intraoperative surgical techniques
• Slowing the progression of the condition and monitoring it post-op
• Early interventions

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

If you haven't yet tuned in for the first November episode of the podcast, MCS enthusiasts will be happy to know the paper discusses temporary MCS devices in acute RV failure.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the Digital Media Editors have three expert guests to discuss their paper, "Pragmatic approach to temporary mechanical circulatory support in acute right ventricular failure."

You'll hear from first author Anthony Carnicelli, MD, from the Medical University of South Carolina; Alexander Bernhardt, MD, from the University Hospital Hamburg-Eppendorf; and senior author Manreet Kanwar, MD, of the Cardiovascular Institute at Allegheny Health Network.

The episode explores:

• Parameters that influence deciding when to escalate RV support
• Determining which device is right for each patient
• Evaluating a patient for the correct anticoagulants
• Device-related complications and solutions
• What's next in research for tMCS and acute RV failure

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Join us again later this month for another MCS study, exploring aortic insufficiency in patients with durable LVADs.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the Digital Media Editors discuss a paper from the October issue of JHLT, entitled "Donor to recipient age matching in lung transplantation: A European experience." Senior author Andrew Fisher, FRCP, PhD joins the podcast to discuss the paper.

You'll hear about:

• European practices in lung transplantation and the donor population
• Main findings and takeaways
• How age disparities in donor matching affect outcomes
• Extended criteria for older donors

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

If you haven't yet tuned in for the first October episode of the podcast, scroll back in the episode history for the latest ISHLT guideline on the evaluation and care of cardiac transplant candidates.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the Digital Media Editors discuss a new guidelines document from the ISHLT entitled "The 2024 ISHLT Guidelines for the Evaluation and Care of Cardiac Transplant Candidates."

The lead co-authors of the document—Yael Peled, MD, and Anique Ducharme, MD, MSc—are on the podcast to discuss the document.

You'll hear about:

• Challenges in drafting such an overarching document
• Highlights for clinicians
• Major changes in the document since the last version
• How changes in durable and temporary MCS affect use of the document

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Join us again later this month for a study on age matching in lung transplantation.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

This month, JHLT: The Podcast reissues our September 2023 tribute to former Editor-in-Chief, Dr. Daniel R. Goldstein. Dr. Goldstein stepped down from his role for health reasons in July 2023; he had been diagnosed with an advanced salivary gland malignancy and felt he would be unable to continue serving JHLT and the International Society for Heart and Lung Transplantation (ISHLT) to his characteristically demanding standard.

Sadly, Dr. Goldstein died on 21 May, 2024, at the age of 56, leaving behind his wife, 2 children, an extended family, and a larger universe of colleagues, collaborators, and mentees who greatly benefited from his equanimity, wisdom, and commitment to his passions.

The tribute, recorded in August 2023, features Michelle Kittleson, MD, PhD, then-Interim Editor-in-Chief of JHLT; Andrew Gelman, PhD, Deputy Editor at JHLT; Andrew Fisher, FRCP, PhD, past president of ISHLT and Past Chair of the Publications Oversight Committee; Daniel Tyrrell, PhD, a former post-doc of Dr. Goldstein's; and Judy Chen, PhD, a former immunology PhD student in Dr. Goldstein's lab.

Two funds were created to allow friends and colleagues to memorialize Dr. Goldstein: the Michigan Biology of Cardiovascular Aging Leadership Development Fund at the Frankel Cardiovascular Center (https://giving.umich.edu/give/393178) and the Adenoid Cystic Carcinoma Foundation (https://accrf.org).

The JHLT has also re-published Dr. Goldstein's farewell message in the September 2024 issue of the Journal. You can read it here: https://www.jhltonline.org/article/S1053-2498(24)01741-8/fulltext

Follow along at www.jhltonline.org/current, or, if you're an ISHLT member, log in at ishlt.org/journal-of-heart-lung-transplantation.  Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

In this special episode of JHLT: The Podcast, the Digital Media Editors connect with Joseph Rogers, MD, the new Editor-in-Chief of JHLT.

In the conversation, Dr. Rogers shares more about his vision for the Journal, how he plans to tackle the challenges and opportunities facing the publication, and a little about his life both inside and outside of medicine.

In addition to being the new Editor-in-Chief, Dr. Rogers is the President and CEO of the Texas Heart Institute in Houston, a past president of the ISHLT, and a prolific contributor to the field of heart and lung transplantation.

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On the second August episode of JHLT: The Podcast, the Digital Media Editors discuss a paper from the August issue of JHLT, entitled "A modular simulation framework for organ allocation."The episode is hosted by Digital Media Editor Erika Lease, MD, FCCP, a transplant pulmonologist from the University of Washington.

The guests for this episode are first author Johnie Rose, MD, PhD, of the Center for Community Health Integration at Case Western Reserve University School of Medicine, and lead author Maryam Valapour, MD, MPP, of the Department of Pulmonary Medicine at the Cleveland Clinic.

In the episode, Drs. Rose and Valapour share the findings from their study, and tackle questions about the limitations of simulation models, what makes their COMET model different from past Simulation Allocation Models (SAMs), and why they made the project open-source.

Follow along at www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this episode of JHLT: The Podcast, the JHLT Digital Media Editors discuss a brand new consensus document from the ISHLT entitled "Strategies to Prevent Hemocompatibility Related Adverse Events in Patients with a Durable, Continuous-Flow Ventricular Assist Device." The episode is hosted by Digital Media Editor Erika Lease, MD, FCCP, a transplant pulmonologist from the University of Washington.

The consensus document's lead author, Ian Hollis, PharmD, a heart failure pharmacist and Associate Professor from the University of North Carolina in Chapel Hill, joins the podcast to discuss the document.  During the discussion, he's reunited with co-author and JHLT Podcast co-host Van-Khue Ton, MD, for a lively discussion of the document's findings and takeaways.

If you work with heart failure patients with durable VADs, you'll want to listen to this episode—and check out the complete document at ISHLT.

Stay tuned for a second episode later this month, where we'll be talking about a modular simulation framework for organ allocation.